nicotine has been researched along with Inflammatory Bowel Diseases in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Auberson, M; Bornand, D; Dulize, R; Guedj, E; Hoeng, J; Lo Sasso, G; Nef, P; Peitsch, MC; Peric, D; Sewer, A; Sierro, N; Tabruyn, SP; Talikka, M; Verhaeghe, C | 1 |
| Liu, X; Qin, Z; Sun, Y; Wan, JJ; Wang, PY; Wei, J; Zhang, Y | 1 |
| AlQasrawi, D; Naser, SA; Qasem, A | 1 |
| Gomes, JP; Shoenfeld, Y; Watad, A | 1 |
| Aldhous, MC; Prescott, RJ; Roberts, S; Samuel, K; Satsangi, J; Waterfall, M | 1 |
| Ben-Horin, S; Chowers, Y | 1 |
| Allais, L; Cuvelier, CA; De Smet, R; Verschuere, S | 1 |
| Grando, SA; Ortiz, A | 1 |
| Blennerhassett, P; Collins, SM; Ghia, JE; Kumar-Ondiveeran, H; Verdu, EF | 1 |
| Martin, M; Scott, DA | 1 |
| Eliakim, R; Karban, A | 1 |
| Hanauer, SB; Kozuch, PL | 1 |
| Bonner, GF | 1 |
| Zijlstra, FJ | 1 |
| Burakoff, R | 1 |
| Guslandi, M | 1 |
| Katz, S | 1 |
| Brampton, C; Chander, CL; Klee, S; Parsons, ME; Sykes, AP; Whelan, C | 1 |
| Ghobrial, G; Miles, H; Naser, SA | 1 |
12 review(s) available for nicotine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Divergent Effect of Cigarette Smoke on Innate Immunity in Inflammatory Bowel Disease: A Nicotine-Infection Interaction.
Topics: Animals; Cigarette Smoking; Humans; Immunity, Innate; Infections; Inflammatory Bowel Diseases; Models, Biological; Nicotine | 2020 |
Nicotine and autoimmunity: The lotus' flower in tobacco.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Behcet Syndrome; Humans; Inflammatory Bowel Diseases; Nicotiana; Nicotine; Sarcoidosis | 2018 |
Neuroimmunology of the gut: physiology, pathology, and pharmacology.
Topics: Anesthetics, Local; Animals; Enteric Nervous System; Gastrointestinal Motility; Gastrointestinal Tract; Humans; Immunity, Cellular; Inflammatory Bowel Diseases; Nicotine; Nicotinic Agonists; Receptor Cross-Talk | 2008 |
The effect of smoking on intestinal inflammation: what can be learned from animal models?
Topics: Animals; Humans; Inflammatory Bowel Diseases; Intestinal Neoplasms; Intestines; Models, Animal; Nicotiana; Nicotine; Oxidative Stress; Risk Factors; Smoking | 2012 |
Smoking and the skin.
Topics: Humans; Inflammatory Bowel Diseases; Nicotine; Pigmentation Disorders; Skin; Skin Aging; Skin Diseases; Skin Neoplasms; Smoking; Stomatitis, Aphthous; Wound Healing | 2012 |
Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases.
Topics: Humans; In Vitro Techniques; Inflammation; Inflammatory Bowel Diseases; Models, Biological; Nicotine; Nicotinic Agonists; Periodontitis; Psoriasis; Receptors, Nicotinic; Sarcoidosis | 2006 |
Effect of smoking on inflammatory bowel disease: Is it disease or organ specific?
Topics: Animals; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestine, Large; Intestine, Small; Nicotine; Risk Factors; Smoking | 2007 |
Treatment of inflammatory bowel disease: a review of medical therapy.
Topics: Aminosalicylic Acids; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Blood Component Removal; Clinical Trials as Topic; Curcumin; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Nicotine; Nicotinic Agonists; Probiotics; Remission Induction; Steroids; Trichuris | 2008 |
Current medical therapy for inflammatory bowel disease.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Crohn Disease; Fatty Acids, Volatile; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Metronidazole; Nicotine | 1996 |
Smoking and nicotine in inflammatory bowel disease: good or bad for cytokines?
Topics: Cytokines; Humans; Inflammatory Bowel Diseases; Nicotine; Smoking | 1998 |
Inflammatory bowel disease workshop. Vail, Colorado, March 22 and 23, 1998. Less commonly used therapies for IBD or treatments on the fringe.
Topics: Anti-Bacterial Agents; Chloroquine; Enteral Nutrition; Fatty Acids, Volatile; Female; Fish Oils; Humans; Inflammatory Bowel Diseases; Male; Nicotine; Prognosis; Randomized Controlled Trials as Topic | 1998 |
Update in medical therapy in inflammatory bowel disease: a clinician's view.
Topics: Adjuvants, Immunologic; Administration, Topical; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Colitis, Ulcerative; Crohn Disease; Dietary Supplements; Disease Management; Heparin; Humans; Inflammatory Bowel Diseases; Nicotine; Nicotinic Agonists; Steroids | 1999 |
7 other study(ies) available for nicotine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Immune System; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Nicotiana; Nicotine | 2023 |
MicroRNA124-IL6R Mediates the Effect of Nicotine in Inflammatory Bowel Disease by Shifting Th1/Th2 Balance Toward Th1.
Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Nicotine; Receptors, Interleukin-6; Signal Transduction; Th1 Cells; Th1-Th2 Balance | 2020 |
Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease?
Topics: Adolescent; Adult; Aged; Analysis of Variance; Apoptosis; Biomarkers; Cell Cycle; Cells, Cultured; Child; Colitis, Ulcerative; Crohn Disease; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Inflammatory Bowel Diseases; Leukocytes, Mononuclear; Male; Middle Aged; Multivariate Analysis; Nicotine; Probability; Reference Values; Sensitivity and Specificity; Smoking; Young Adult | 2008 |
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.
Topics: Animals; Anticoagulants; Appetite Depressants; Dextran Sulfate; Dinitrofluorobenzene; Disease Models, Animal; Eating; Ganglionic Blockers; Ganglionic Stimulants; Hexamethonium; Inflammatory Bowel Diseases; Macrophage Colony-Stimulating Factor; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neural Inhibition; Nicotine; Pylorus; Sincalide; Vagotomy; Vagus Nerve | 2006 |
Nonorthodox therapeutic practices in inflammatory bowel disease.
Topics: Complementary Therapies; Humans; Inflammatory Bowel Diseases; Nicotine | 1999 |
An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Leukemia; Leukotriene B4; Male; Nicotine; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Effect of nicotine on inflammatory bowel disease.
Topics: Humans; Inflammatory Bowel Diseases; Mycobacterium avium; Nicotine; Nicotinic Agonists; Species Specificity | 2001 |